BIOMAT Database Logo BIOMAT Database Logo

Transcriptional and translational regulatory mechanisms during normal aging of the mammalian brain and in Alzheimer's disease. 1986

C A Marotta, and R E Majocha, and J F Coughlin, and H J Manz, and P Davies, and M Ventosa-Michelman, and W G Chou, and S B Zain, and E M Sajdel-Sulkowska

UI MeSH Term Description Entries
D011499 Protein Processing, Post-Translational Any of various enzymatically catalyzed post-translational modifications of PEPTIDES or PROTEINS in the cell of origin. These modifications include carboxylation; HYDROXYLATION; ACETYLATION; PHOSPHORYLATION; METHYLATION; GLYCOSYLATION; ubiquitination; oxidation; proteolysis; and crosslinking and result in changes in molecular weight and electrophoretic motility. Amino Acid Modification, Post-Translational,Post-Translational Modification,Post-Translational Protein Modification,Posttranslational Modification,Protein Modification, Post-Translational,Amino Acid Modification, Posttranslational,Post-Translational Amino Acid Modification,Post-Translational Modifications,Post-Translational Protein Processing,Posttranslational Amino Acid Modification,Posttranslational Modifications,Posttranslational Protein Processing,Protein Processing, Post Translational,Protein Processing, Posttranslational,Amino Acid Modification, Post Translational,Modification, Post-Translational,Modification, Post-Translational Protein,Modification, Posttranslational,Modifications, Post-Translational,Modifications, Post-Translational Protein,Modifications, Posttranslational,Post Translational Amino Acid Modification,Post Translational Modification,Post Translational Modifications,Post Translational Protein Modification,Post Translational Protein Processing,Post-Translational Protein Modifications,Processing, Post-Translational Protein,Processing, Posttranslational Protein,Protein Modification, Post Translational,Protein Modifications, Post-Translational
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D004274 DNA, Recombinant Biologically active DNA which has been formed by the in vitro joining of segments of DNA from different sources. It includes the recombination joint or edge of a heteroduplex region where two recombining DNA molecules are connected. Genes, Spliced,Recombinant DNA,Spliced Gene,Recombinant DNA Research,Recombination Joint,DNA Research, Recombinant,Gene, Spliced,Joint, Recombination,Research, Recombinant DNA,Spliced Genes
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000367 Age Factors Age as a constituent element or influence contributing to the production of a result. It may be applicable to the cause or the effect of a circumstance. It is used with human or animal concepts but should be differentiated from AGING, a physiological process, and TIME FACTORS which refers only to the passage of time. Age Reporting,Age Factor,Factor, Age,Factors, Age
D000375 Aging The gradual irreversible changes in structure and function of an organism that occur as a result of the passage of time. Senescence,Aging, Biological,Biological Aging
D000544 Alzheimer Disease A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57) Acute Confusional Senile Dementia,Alzheimer's Diseases,Dementia, Alzheimer Type,Dementia, Senile,Presenile Alzheimer Dementia,Senile Dementia, Alzheimer Type,Alzheimer Dementia,Alzheimer Disease, Early Onset,Alzheimer Disease, Late Onset,Alzheimer Sclerosis,Alzheimer Syndrome,Alzheimer Type Senile Dementia,Alzheimer's Disease,Alzheimer's Disease, Focal Onset,Alzheimer-Type Dementia (ATD),Dementia, Presenile,Dementia, Primary Senile Degenerative,Early Onset Alzheimer Disease,Familial Alzheimer Disease (FAD),Focal Onset Alzheimer's Disease,Late Onset Alzheimer Disease,Primary Senile Degenerative Dementia,Senile Dementia, Acute Confusional,Alzheimer Dementias,Alzheimer Disease, Familial (FAD),Alzheimer Diseases,Alzheimer Type Dementia,Alzheimer Type Dementia (ATD),Alzheimers Diseases,Dementia, Alzheimer,Dementia, Alzheimer-Type (ATD),Familial Alzheimer Diseases (FAD),Presenile Dementia,Sclerosis, Alzheimer,Senile Dementia
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012313 RNA A polynucleotide consisting essentially of chains with a repeating backbone of phosphate and ribose units to which nitrogenous bases are attached. RNA is unique among biological macromolecules in that it can encode genetic information, serve as an abundant structural component of cells, and also possesses catalytic activity. (Rieger et al., Glossary of Genetics: Classical and Molecular, 5th ed) RNA, Non-Polyadenylated,Ribonucleic Acid,Gene Products, RNA,Non-Polyadenylated RNA,Acid, Ribonucleic,Non Polyadenylated RNA,RNA Gene Products,RNA, Non Polyadenylated
D012323 RNA Processing, Post-Transcriptional Post-transcriptional biological modification of messenger, transfer, or ribosomal RNAs or their precursors. It includes cleavage, methylation, thiolation, isopentenylation, pseudouridine formation, conformational changes, and association with ribosomal protein. Post-Transcriptional RNA Modification,RNA Processing,Post-Transcriptional RNA Processing,Posttranscriptional RNA Processing,RNA Processing, Post Transcriptional,RNA Processing, Posttranscriptional,Modification, Post-Transcriptional RNA,Modifications, Post-Transcriptional RNA,Post Transcriptional RNA Modification,Post Transcriptional RNA Processing,Post-Transcriptional RNA Modifications,Processing, Posttranscriptional RNA,Processing, RNA,RNA Modification, Post-Transcriptional,RNA Modifications, Post-Transcriptional

Related Publications

C A Marotta, and R E Majocha, and J F Coughlin, and H J Manz, and P Davies, and M Ventosa-Michelman, and W G Chou, and S B Zain, and E M Sajdel-Sulkowska
Topography of brain atrophy during normal aging and Alzheimer's disease.
January 1996, Neurobiology of aging,
C A Marotta, and R E Majocha, and J F Coughlin, and H J Manz, and P Davies, and M Ventosa-Michelman, and W G Chou, and S B Zain, and E M Sajdel-Sulkowska
Cholesterol and synaptic compensatory mechanisms in Alzheimer's disease mice brain during aging.
January 2012, Journal of Alzheimer's disease : JAD,
C A Marotta, and R E Majocha, and J F Coughlin, and H J Manz, and P Davies, and M Ventosa-Michelman, and W G Chou, and S B Zain, and E M Sajdel-Sulkowska
The blood-brain barrier in Alzheimer's disease and normal aging.
January 1988, Neurobiology of aging,
C A Marotta, and R E Majocha, and J F Coughlin, and H J Manz, and P Davies, and M Ventosa-Michelman, and W G Chou, and S B Zain, and E M Sajdel-Sulkowska
Quantitative brain SPECT in Alzheimer's disease and normal aging.
November 1993, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
C A Marotta, and R E Majocha, and J F Coughlin, and H J Manz, and P Davies, and M Ventosa-Michelman, and W G Chou, and S B Zain, and E M Sajdel-Sulkowska
Genome-wide analysis reveals mechanisms modulating autophagy in normal brain aging and in Alzheimer's disease.
August 2010, Proceedings of the National Academy of Sciences of the United States of America,
C A Marotta, and R E Majocha, and J F Coughlin, and H J Manz, and P Davies, and M Ventosa-Michelman, and W G Chou, and S B Zain, and E M Sajdel-Sulkowska
[Biochemical aspects on normal aging and Alzheimer's disease. The aging of the brain].
January 1986, Nordisk medicin,
C A Marotta, and R E Majocha, and J F Coughlin, and H J Manz, and P Davies, and M Ventosa-Michelman, and W G Chou, and S B Zain, and E M Sajdel-Sulkowska
Advances at the intersection of normal brain aging and Alzheimer's disease.
March 2017, Behavioural brain research,
C A Marotta, and R E Majocha, and J F Coughlin, and H J Manz, and P Davies, and M Ventosa-Michelman, and W G Chou, and S B Zain, and E M Sajdel-Sulkowska
A systems level analysis of transcriptional changes in Alzheimer's disease and normal aging.
February 2008, The Journal of neuroscience : the official journal of the Society for Neuroscience,
C A Marotta, and R E Majocha, and J F Coughlin, and H J Manz, and P Davies, and M Ventosa-Michelman, and W G Chou, and S B Zain, and E M Sajdel-Sulkowska
[Post-translational and transcriptional regulatory mechanisms of Arabidopsis circadian clocks].
December 2013, Seikagaku. The Journal of Japanese Biochemical Society,
C A Marotta, and R E Majocha, and J F Coughlin, and H J Manz, and P Davies, and M Ventosa-Michelman, and W G Chou, and S B Zain, and E M Sajdel-Sulkowska
Brain imaging evidence of preclinical Alzheimer's disease in normal aging.
April 2006, Annals of neurology,
Copied contents to your clipboard!